Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin
Published
Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.
Full Article